MNPR Stock Performance and Key Statistics

MNPR has a current P/E ratio of -1.19

The MNPR stock has a trailing twelve month price-to sales (P/S) ratio of N/A while its price-to-book (P/B) value is 314.35.

MNPR's price-to-free-cashflow (P/FCF) ratio is -45.29, an indicator that is currently being trending upward.

Based on MNPR's recent bid, its distance from 20 days simple moving average is 42.55%. It is 75.24% apart from 50 days simple moving average, and it is 339.45% apart from 200 days simple moving average.

The 52-week high for MNPR is $49.98 which is 6.03% away from the current price level whereas the distance of that from the 52-week low of $1.54 stands at 3,006.8%.

The performance of MNPR stock was not encouraging with most of its significant price indicators in green. Monopar Therapeutics Inc.(NASDAQ: MNPR) shares have moved upward +10.22% or $4.45 in the latest trading session and have gained 118.18% year-to-date (YTD). The stock has gained nearly 14,207% over the past year. After moving 227.2% over the trailing 3-month period, the stock is 6,824.41% higher in the 6-month period. Looking at its performance over the shorter term, it'sgained 14.78% a week and 118.18% a month.

The current 14-day RSI for MNPR stock is 70.23. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.

ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Monopar Therapeutics Inc. (MNPR) has a 14-day ATR of 5.08.

After closing at $43.55 with 6.1M of its shares outstanding, the current enterprise value of MNPR is roughly 4.2M.

Monopar Therapeutics Inc. (NASDAQ: MNPR) is up 14,207% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 21.77%. MNPR stock price is also up 118.18% on its value in year-to-date trading.

The number outstanding shares of MNPR is 6.1M, and of these 76.63% shares are freely available for trading. On average, MNPR stock has traded 83.87K shares per day for the past 10 days. A total of 80.3K shares changed hands during the last trading session with the average session volume of 90.3K shares.